找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Gallbladder Cancer; Current Treatment Op Vijay Kumar Shukla,Manoj Pandey,Ruhi Dixit Book 2023 The Editor(s) (if applicable) and The Author(

[復制鏈接]
樓主: ARGOT
41#
發(fā)表于 2025-3-28 16:55:18 | 只看該作者
42#
發(fā)表于 2025-3-28 18:59:41 | 只看該作者
43#
發(fā)表于 2025-3-29 02:17:24 | 只看該作者
https://doi.org/10.1007/978-3-663-09225-4common symptoms present at an advanced stage. Conventional chemotherapy and radiation have not shown much improvement in terms of survival and quality of life. MicroRNA technology is a novel and exciting development in cancer diagnostic and therapeutic and may potentially address shortcomings relate
44#
發(fā)表于 2025-3-29 03:48:06 | 只看該作者
45#
發(fā)表于 2025-3-29 10:44:39 | 只看該作者
Agenda-Setting zwischen Parlament und Medienrld precluded it from active research for the last two decades. Gemcitabine- and platinum-based combination therapy remained the treatment of choice over these years. Delayed presentations and aggressive biology made this disease largely incurable in early disease state and goal remains palliative i
46#
發(fā)表于 2025-3-29 13:02:51 | 只看該作者
47#
發(fā)表于 2025-3-29 17:09:40 | 只看該作者
48#
發(fā)表于 2025-3-29 19:56:44 | 只看該作者
The Analysis of Business Processestage of disease. There is a need for an effective treatment regimen to circumvent the high mortality rate. Current therapeutic approach is the surgical resection followed by chemotherapy and radiotherapy. Recent advancements in high throughput sequencing technology, whole proteome and transcriptome
49#
發(fā)表于 2025-3-30 03:06:24 | 只看該作者
Vijay Kumar Shukla,Manoj Pandey,Ruhi DixitSurgical Management, Adjuvant Chemotherapy and Palliative Chemotherapy in gallbladder cancer.Targeted Therapies in gallbladder cancer.Clinical trials in gallbladder cancer treatment
50#
發(fā)表于 2025-3-30 07:22:23 | 只看該作者
https://doi.org/10.1007/978-981-19-6442-8Gallbladder Cancer; Cholelithiasis; Cholecystectomy; Chemotherapy; Therapeutics
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 15:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
贵港市| 四川省| 绥德县| 揭东县| 金昌市| 洛隆县| 云南省| 库伦旗| 邵阳县| 保山市| 连平县| 湖南省| 合阳县| 黄山市| 双牌县| 巢湖市| 临湘市| 永嘉县| 仙游县| 武汉市| 湄潭县| 南昌县| 林周县| 吉水县| 灵台县| 察雅县| 扎赉特旗| 芦山县| 张北县| 柳江县| 赤城县| 乌兰浩特市| 互助| 兴义市| 米林县| 开江县| 堆龙德庆县| 灵武市| 时尚| 呼伦贝尔市| 连山|